Canadians currently pay anywhere from $300 to $500 per month for GLP-1 medications, including semaglutide brands such as Ozempic and Wegovy
For instance, retatrutide trials typically enroll individuals with comorbid conditions such as hypertension or fatty liver and monitor additional endpoints such as knee pain
Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction
Much of the research over the last couple of decades has focused on thrombosis and reducing the risk of excessive blood clotting, as this is substantially associated with vascular stiffness, reduced blood flow, and an increased risk of embolism, cardiovascular disease, and heart failure
Tuesday night, as you know, Katrina, because youve been on, we have an integrative medicine webinar every Tuesday night eight oclock eastern five PM Pacific, and weve been doing it for two and a half years